Metraipolis › archive › dc_ee18071b97aa

Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication — Europe PMC PMID:37801446

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37801446
DOI
10.1371/journal.ppat.1011660
License (as archived)
CC0-1.0
Archived
2026-10-07T12:01:23.488Z
SHA-256 of the archived text
1fef76c35a4cc5bb765c1b12d08f2ff101278d3bacd71e3afed214ac9765a847
Stable URL of this page
https://metraipolis.com/documento/dc_ee18071b97aa

How to cite

Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication — Europe PMC PMID:37801446 — Europe PMC (en), https://europepmc.org/article/MED/37801446 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ee18071b97aa (Metraipolis archive dc_ee18071b97aa, sha256 1fef76c35a4cc5bb765c1b12d08f2ff101278d3bacd71e3afed214ac9765a847)
BibTeX
@misc{dcee18071b97aa,
  title = {Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication — Europe PMC PMID:37801446},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37801446},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ee18071b97aa; sha256 1fef76c35a4cc5bb765c1b12d08f2ff101278d3bacd71e3afed214ac9765a847},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37801446. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

One approach to 'functional cure' of HIV infection is to induce durable control of HIV replication after the interruption of antiretroviral therapy (ART). However, the major factors that determine the viral 'setpoint' level after treatment interruption are not well understood. Here we combine data on ART interruption following SIV infection for 124 total animals from 10 independent studies across 3 institutional cohorts to understand the dynamics and predictors of post-treatment viral control. We find that the timing of treatment initiation is an important determinant of both the peak and early setpoint viral levels after treatment interruption. During the first 3 weeks of infection, every day of delay in treatment initiation is associated with a 0.22 log10 copies/ml decrease in post-rebound peak and setpoint viral levels. However, delay in initiation of ART beyond 3 weeks of infection is associated with higher post-rebound setpoint viral levels. For animals treated beyond 3 weeks post-infection, viral load at ART initiation was the primary predictor of post-rebound setpoint viral levels. Potential alternative predictors of post-rebound setpoint viral loads including cell-associated DNA or RNA, time from treatment interruption to rebound, and pre-interruption CD8+ T cell responses were also examined in the studies where these data were available. This analysis suggests that optimal timing of treatment initiation may be an important determinant of post-treatment control of HIV.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2023 (prima pubblicazione 2023-10-06).
Identificativi: PMID 37801446 · PMCID PMC10558076 · DOI 10.1371/journal.ppat.1011660.
Descrittori MeSH principali: HIV Infections.
Pagina: https://europepmc.org/article/MED/37801446 — https://doi.org/10.1371/journal.ppat.1011660. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:31:06.927Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.